Limited-angle x-ray luminescence tomography: methodology and feasibility study

X-ray luminescence tomography (XLT) has recently been proposed as a new imaging modality for biological imaging applications. This modality utilizes phosphor nanoparticles which luminesce near-infrared light when excited by x-ray photons. The advantages of this modality are that it uniquely combines the high sensitivity of radioluminescent nanoparticles and the high spatial localization of collimated x-ray beams. Currently, XLT has been demonstrated using x-ray spatial encoding to resolve the imaging volume. However, there are applications where the x-ray excitation may be limited by geometry, where increased temporal resolution is desired, or where a lower dose is mandatory. This paper extends the utility of XLT to meet these requirements by incorporating a photon propagation model into the reconstruction algorithm in an x-ray limited-angle (LA) geometry. This enables such applications as image-guided surgery, where the ability to resolve lesions at depths of several centimeters can be the key to successful resection. The hybrid x-ray/diffuse optical model is first formulated and then demonstrated in a breast-sized phantom, simulating a breast lumpectomy geometry. Both numerical and experimental phantoms are tested, with lesion-simulating objects of various sizes and depths. Results show localization accuracy with median error of 2.2 mm, or 4% of object depth, for small 2–14 mm diameter lesions positioned from 1 to 4.5 cm in depth. This compares favorably with fluorescence optical imaging, which is not able to resolve such small objects at this depth. The recovered lesion size has lower size bias in the x-ray excitation direction than the optical direction, which is expected due to the increased optical scatter. However, the technique is shown to be quite invariant in recovered size with respect to depth, as the standard deviation is less than 2.5 mm. Sensitivity is a function of dose; radiological doses are found to provide sufficient recovery for µg ml−1 concentrations, while therapy dosages provide recovery for ng ml−1 concentrations. Experimental phantom results agree closely with the numerical results, with positional errors recovered within 8.6% of the effective depth for a 5 mm object, and within 5.2% of the depth for a 10 mm object. Object-size median error is within 2.3% and 2% for the 5 and 10 mm objects, respectively. For shallow-to-medium depth applications where optical and radio-emission imaging modalities are not ideal, such as in intra-operative procedures, LAXLT may be a useful tool to detect molecular signatures of disease.

[1]  Xiaoyao Fan,et al.  Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. , 2011, Journal of neurosurgery.

[2]  Lei Xing,et al.  Facile Synthesis of Amine-Functionalized Eu3+-Doped La(OH)3 Nanophosphors for Bioimaging , 2010, Nanoscale research letters.

[3]  Lei Xing,et al.  Tomographic molecular imaging of x-ray-excitable nanoparticles. , 2010, Optics letters.

[4]  L Xing,et al.  Hybrid x-ray/optical luminescence imaging: characterization of experimental conditions. , 2010, Medical physics.

[5]  Lei Xing,et al.  X-Ray Luminescence Computed Tomography via Selective Excitation: A Feasibility Study , 2010, IEEE Transactions on Medical Imaging.

[6]  Matthew J Schipper,et al.  Medical decision making regarding computed tomographic radiation dose and associated risk: the patient's perspective. , 2009, Archives of internal medicine.

[7]  F. Dirbas Accelerated partial breast irradiation: where do we stand? , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  T. Knöös,et al.  Kilovoltage x-ray dosimetry—an experimental comparison between different dosimetry protocols , 2008, Physics in medicine and biology.

[9]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[10]  Veit Rohde,et al.  EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME: IDENTIFICATION OF AND ADJUSTMENT FOR BIAS , 2008, Neurosurgery.

[11]  Wei Chen,et al.  Nanoparticle fluorescence based technology for biological applications. , 2008, Journal of nanoscience and nanotechnology.

[12]  W. Steers,et al.  Fiberoptic imaging of cavernous nerves in vivo. , 2007, The Journal of urology.

[13]  A. Munshi External hypofractionated whole-breast radiotherapy: now where does accelerated partial breast irradiation stand? , 2007, Journal of cancer research and therapeutics.

[14]  Hamid Dehghani,et al.  Subsurface diffuse optical tomography can localize absorber and fluorescent objects but recovered image sensitivity is nonlinear with depth. , 2007, Applied optics.

[15]  Hak Soo Choi,et al.  Image-Guided Oncologic Surgery Using Invisible Light: Completed Pre-Clinical Development for Sentinel Lymph Node Mapping , 2006, Annals of Surgical Oncology.

[16]  G. Ross Accelerated partial breast irradiation: technically feasible but who will benefit? , 2005, Breast Cancer Research.

[17]  R. Moats,et al.  In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts , 2004, Cancer Research.

[18]  J. Frangioni In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[19]  Michele Follen,et al.  Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. , 2003, Cancer research.

[20]  B. Cady,et al.  A Comparison of Ink-Directed and Traditional Whole-Cavity Re-Excision for Breast Lumpectomy Specimens With Positive Margins , 2001, Annals of Surgical Oncology.

[21]  S M Seltzer,et al.  AAPM protocol for 40-300 kV x-ray beam dosimetry in radiotherapy and radiobiology. , 2001, Medical physics.

[22]  Sibylle Ziegler,et al.  Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography , 2001 .

[23]  M. Schwaiger,et al.  Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. , 2001, Cancer research.

[24]  H Stepp,et al.  Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.

[25]  M. Makuuchi,et al.  A new technical aspect of ultrasound-guided liver surgery. , 1999, American journal of surgery.

[26]  F Verhaegen,et al.  Monte Carlo modelling of radiotherapy kV x-ray units. , 1999, Physics in medicine and biology.

[27]  A. Fortin,et al.  Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  H. Jiang,et al.  Frequency-domain fluorescent diffusion tomography: a finite-element-based algorithm and simulations. , 1998, Applied optics.

[29]  I. Kandarakis,et al.  X-ray induced luminescence and spatial resolution of phosphor screens , 1996 .

[30]  I. Kandarakis,et al.  X-ray induced luminescence and spatial resolution of La2O2S:Tb phosphor screens. , 1996, Physics in medicine and biology.

[31]  M. Schweiger,et al.  The finite element method for the propagation of light in scattering media: boundary and source conditions. , 1995, Medical physics.

[32]  R. Aronson,et al.  Boundary conditions for diffusion of light. , 1995, Journal of the Optical Society of America. A, Optics, image science, and vision.

[33]  D. Boas,et al.  Experimental images of heterogeneous turbid media by frequency-domain diffusing-photon tomography. , 1995, Optics letters.

[34]  M. Schweiger,et al.  A finite element approach for modeling photon transport in tissue. , 1993, Medical physics.

[35]  D. Krag,et al.  Gamma-probe guided localization of lymph nodes. , 1993, Surgical oncology.

[36]  A. Welch,et al.  A review of the optical properties of biological tissues , 1990 .

[37]  H H Barrett,et al.  Limited-angle tomography for the nineties. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  M S Patterson,et al.  Optical properties of normal and diseased human breast tissues in the visible and near infrared. , 1990, Physics in medicine and biology.

[39]  V G Peters,et al.  Optical properties of normal and diseased human breast tissues in the visible and near infrared , 1990 .

[40]  H. C. Robertson,et al.  Hematoporphyrin‐Derivative Fluorescence in Malignant Neoplasms , 1968, Journal of the South Carolina Medical Association.

[41]  Green Jf,et al.  HEMATOPORPHYRIN-DERIVATIVE FLUORESCENCE IN MALIGNANT NEOPLASMS. , 1965 .

[42]  D. Marquardt An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .